Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 EUR | -0.92% | +9.09% | -56.54% |
03/05 | Crossject: praised for extended agreement on Zepizure | CF |
02/05 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.54% | 89.36M | |
-7.60% | 196M |
- Stock Market
- Equities
- ALCJ Stock
- News Crossject
- France's Crossject Inks New Commercialization Deal for Epileptic Seizure Therapy in Northern EU